FR1120M - Drug combinations comprising sodium formaldehyde sulfoxylate and the sodium salt of n- (methylene sulfoxylate) isonicotinoyl hydrazide intended for the treatment of tuberculosis and leprosy. - Google Patents

Drug combinations comprising sodium formaldehyde sulfoxylate and the sodium salt of n- (methylene sulfoxylate) isonicotinoyl hydrazide intended for the treatment of tuberculosis and leprosy.

Info

Publication number
FR1120M
FR1120M FR858382A FR858382A FR1120M FR 1120 M FR1120 M FR 1120M FR 858382 A FR858382 A FR 858382A FR 858382 A FR858382 A FR 858382A FR 1120 M FR1120 M FR 1120M
Authority
FR
France
Prior art keywords
sulfoxylate
leprosy
tuberculosis
methylene
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR858382A
Other languages
French (fr)
Inventor
Albert German
Tran Ba Loc
Painvin Nee Yvonne Fremin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PAINVIN
TRAN BA LOC
Original Assignee
PAINVIN
TRAN BA LOC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PAINVIN, TRAN BA LOC filed Critical PAINVIN
Priority to FR858382A priority Critical patent/FR1120M/en
Application granted granted Critical
Publication of FR1120M publication Critical patent/FR1120M/en
Priority to GB14030/62A priority patent/GB967133A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86—Hydrazides; Thio or imino analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR858382A 1961-04-11 1961-04-11 Drug combinations comprising sodium formaldehyde sulfoxylate and the sodium salt of n- (methylene sulfoxylate) isonicotinoyl hydrazide intended for the treatment of tuberculosis and leprosy. Expired FR1120M (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR858382A FR1120M (en) 1961-04-11 1961-04-11 Drug combinations comprising sodium formaldehyde sulfoxylate and the sodium salt of n- (methylene sulfoxylate) isonicotinoyl hydrazide intended for the treatment of tuberculosis and leprosy.
GB14030/62A GB967133A (en) 1961-04-11 1962-04-11 Improvements in or relating to anti-tubercular and anti-leprotic pharmaceutical compositions comprising isonicotinoyl hydrazine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR858382A FR1120M (en) 1961-04-11 1961-04-11 Drug combinations comprising sodium formaldehyde sulfoxylate and the sodium salt of n- (methylene sulfoxylate) isonicotinoyl hydrazide intended for the treatment of tuberculosis and leprosy.

Publications (1)

Publication Number Publication Date
FR1120M true FR1120M (en) 1962-02-12

Family

ID=8752806

Family Applications (1)

Application Number Title Priority Date Filing Date
FR858382A Expired FR1120M (en) 1961-04-11 1961-04-11 Drug combinations comprising sodium formaldehyde sulfoxylate and the sodium salt of n- (methylene sulfoxylate) isonicotinoyl hydrazide intended for the treatment of tuberculosis and leprosy.

Country Status (2)

Country Link
FR (1) FR1120M (en)
GB (1) GB967133A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455234A (en) * 1994-03-16 1995-10-03 Ahluwalia; Gurpreet S. Inhibition of hair growth

Also Published As

Publication number Publication date
GB967133A (en) 1964-08-19

Similar Documents

Publication Publication Date Title
NL148313B (en) PROCESS FOR THE PREPARATION OF THERAPEUTIC PREPARATIONS, AND FOR THE PREPARATION OF SUITABLE N-SUBSTITUTED LACTAMS.
NL7614230A (en) TOMOGRAPHIC DEVICE AND METHOD FOR RE-CONSTRUCTING THIN, FLAT PREPARATIONS FROM NON-ABSORBED AND NON-SCATTERED RADIATION.
OA00928A (en) Cosmetic agent and method of preparation.
DK125262B (en) Bactericides, fungicides, nematocides and algicides.
FI46382C (en) Process for the preparation of therapeutically valuable semicarbazones and thiosemicarbazones of 1-methyl-2-formyl and 1-methyl-2-acetyl-5-nitroimidazole.
NL165785B (en) PROCESS FOR PREPARING INHIBITORS OF PROTEOLYTIC ENZYMES AND THERAPEUTIC PREPARATIONS MADE THEREOF
FR1120M (en) Drug combinations comprising sodium formaldehyde sulfoxylate and the sodium salt of n- (methylene sulfoxylate) isonicotinoyl hydrazide intended for the treatment of tuberculosis and leprosy.
FR1121M (en) Drug combinations comprising sodium formaldehyde sulfoxylate and isoniazid, intended for the treatment of tuberculosis and leprosy.
BE618563A (en) New N- (monooxy) -amino-triazines and their preparation
BE623942A (en) Substituted imidazolidinones and imidazolidinethiones and their preparation.
FI49502C (en) Process for the preparation of N-substituted 1,4-dihydro-3-carboxy-cycloalkanoquinolones (4) having antimidribly active activity
FR363M (en) New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.
BE615690A (en) 3,3-Bis- (4-pyridoyl-amino-phenyl) -butan-2-ones and processes for their preparation
BE599031A (en) Therapeutic agents derived from morphine and their preparation.
FR1134M (en) Drug consisting of choline pyrrolidone carboxylate.
BE611598A (en) Isonicotinic acid hydrazide derivative and process for its preparation.
GR23379B (en) METHOD OF PREPARATION OF NEW HETEROCYCLIC PRODUCTS.
GR21988B (en) METHOD OF PREPARATION OF PHARMACEUTICAL SPECIFICATION AGAINST ELCUSE, STOMACH AND GASTRITIS.
FR3054M (en) Pharmaceutical preparations.
FR2879M (en) 4,4,14-trimethylpregnenes and lactones of corresponding 21 acids.
DK102910C (en) Process for the preparation of benzenesulfonylureas and their salts.
FR1915M (en) New alkaloid and its derivatives.
BE598428A (en) Benzylguanidine derivatives, processes and pharmaceutical preparations containing them
FR3742M (en) New drugs for the treatment of tuberculosis and leprosy comprising a salt of isonicotinoyl hydrazine methane sulfinic acid.
FR1699M (en) New drug, especially for the treatment of spasms of vascular and visceral origin.